Atypical Femur Fractures (AFF) are associated with Bisphosphonate Osteoporosis Therapy. Bisphosphonate therapy is widely used as the GoldStandard Therapy for Osteoporosis: it increases bone density and reduce the risk of vertebral, nonvertebral and hip fractures. However, longterm alendronic acid administration can causes severely
Patient was on Alendronic Acid 70 mg once a week for postmenopausal osteoporosis for more than 5 years.
On rst physical examination, there was a severe bilateral pain in mid-thigh: it was performed a X-Ray of right femur showing a lateral cortex thickening and a transverse fracture line of the mid-thigh (Figure 2 ). e patient used vitamin D supplies but vitamin D (25-OH) blood level was very low. e patient was referred to Orthopaedic Surgery and underwent the closed reduction and internal xation with IMHS (Intra Medullary Hip Screw) to both femoral sha s (Figures 3 and 4) . Surgery outcome was good with no complications. e patient was kept under observation with 25-hydroxycholecalciferol (Calcifediol) supplementation. e clinic follow-up was based on periodic examinations and 1-3-6-12 months postoperative X-Rays (Figures 5-10 ).
e patient was discharged ambulating using two crutches with no pain. Active hip exion 90 degrees and passive 100 degrees.
Discussion
AFF can occur in patients treated with long-term alendronate therapy [3] . e incidence of these kind of fractures is estimated in 78 cases per 100,000 patients taking oral bisphosphonates [4] for more than 5 years [5, 6] . e half-life of bisphosphonate is more than 10 years and it exerts its e ects even a er cessation of therapy [4] . e ability of bone to remodel may be impaired by long term administration of bisphosphonate because it induces prolonged suppression of bone turnover, accumulation of micro-damage and it compromises the bone strength and leads to insu ciency stress fracture [7] , but the AFF pathogenetic mechanism has not been de ned yet.
e American Society for Bone and Mineral Research (ASBMR) task force suggested several possibile pathogenic mechanisms [7] : 5. Variation in bone turnover rate. 1. Generalized increase in cortical thickness of the femoral diaphysis.
2. Unilateral or bilateral prodromal symptoms, such as dull or aching pain in the groin or thigh.
3. Bilateral incomplete or complete femoral diaphysis fracture.
Delayed healing.
We can diagnose AFF if major criteria exist.
Pain, typically sharp, well-localized to the mid or upper thigh, for several weeks to months prior to the fracture are prodromal clinical features. As described by Rizzoli et al. [8] fractures occur with minimal or no trauma and Giusti et al. [3] reported about 40% of these fracture occurred with no trauma history. When a patient has such a kind of features in a long-term alendronate therapy the rst exam to perform is bilateral radiographs of the femur looking for stress reaction and then if necessary MRI. e clinical features of these fractures are prodromal pain, typically sharp, well-localized to the mid or upper thigh, for several weeks to months prior to the fracture [3] . As described by Rizzoli et al. [8] fractures occur with minimal or no trauma and Giusti et al. [3] reported about 40% of these fracture occurred with no trauma history. erefore, critical evaluation of patients on long-term bisphosphonate therapy presenting with pain in the thigh is required. Routine bilateral radiographs of the femur looking for stress reaction is required and if necessary, advanced imaging such as bone scan or magnetic resonance imaging should be considered. Silverman and Christiansen [1] proposed the concept of a "drug holiday", based on evidence of sustained protection from increased bone turnover and fracture in patients who had received bisphosphonate therapy 5 or more years.
Conclusion
In conclusion, we suggest discontinuation of long-term bisphosphonate therapy a er 4-5 years in patient with osteoporosis and, in case of thigh pain, we ask for X-Rays in order to con rm the diagnosis of AFF. e orthopedic surgical therapy can be closed reduction and internal xation. Orthopedic follow-up is based on periodic clinical examinations and 1-3-6-12 months postoperative X-Rays.
6. Reduced vascularity and anti-angiogenic e ect. e ASBMR set major and minor diagnosis criteria. e major criteria are:
1. e fracture is associated with no or minimal trauma, as in a fall from standing height or less.
2. e fracture line originates at the lateral cortex and is substantially transverse in its orientation, although it may become oblique as it progresses medially across the femur.
3. Complete fractures extend through both cortices and may be associated with a medial spike, whereas incomplete fractures involve only the lateral cortex.
4. e fracture is un-comminuted or minimally comminuted.
5. Localized periosteal or endosteal thickening of the lateral cortex is present at the fracture site ("breaking" or " aring").
e minor criteria are:
